For instance, alterations in genes such as RB1, TP53, and PTEN, as well as increased MYCN amplification, have been identified as key drivers in the development of neuroendocrine PC (NEPC), a molecular PC subtype that emerges after ADT failure [12]. The gene discussed is TP53; the disease is pachyonychia congenita.